Calvin Sandra Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$1.34M

Insider Activity of Calvin Sandra

According to the SEC Form 4 filings, Calvin Sandra, being in a position of

  1. SVP, CHIEF ACCOUNTING OFFICER at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 109112 shares for $4.19M,
    over all time since 2022-01-24, has bought 0 shares, and sold 174652 shares for $5.54M.

Biography of Calvin Sandra

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $4,193,7566100

Comparison of Insiders on Amount of Buys and Sells

2026-09-15SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
5,375
0.0058%
$62.33$335,005-15.55%
2026-04-14SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
21,977
0.0311%
$41.07$902,595+31.88%
2026-02-03SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
4,333
0.0047%
$32.12$139,176+53.44%
2025-12-24SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
7,402
0.0082%
$40.00$296,080+14.65%
2025-12-15SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
2,910
0.0034%
$36.00$104,760+29.39%
2025-11-04SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
67,115
0.0768%
$36.00$2.42M+25.26%
2025-02-11SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
24,244
0.033%
$25.00$606,100-11.2%
2025-02-03SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
3,348
0.0038%
$20.12$67,362+4.3%
2025-01-22SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
925
0.001%
$18.94$17,520+6.94%
2024-12-26SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
15,000
0.0166%
$17.22$258,278+12.77%
2024-11-25SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
12,090
0.0139%
$18.30$221,258+4.68%
2024-02-01SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
2,820
0.0036%
$8.53$24,058+5.29%
2024-01-23SaleTravere Therapeutics, Inc.
TVTX
SVP, CHIEF ACCOUNTING OFFICER
910
0.0012%
$9.07$8,252-3.12%
2023-05-11SaleTravere Therapeutics, Inc.
TVTX
SVP, Chief Accounting Officer
122
0.0002%
$16.12$1,967-46.41%
2023-05-10SaleTravere Therapeutics, Inc.
TVTX
SVP, Chief Accounting Officer
436
0.0007%
$16.59$7,233-46.81%
2023-02-02SaleTravere Therapeutics, Inc.
TVTX
SVP, Chief Accounting Officer
360
0.0005%
$22.42$8,071-32.02%
2023-02-01SaleTravere Therapeutics, Inc.
TVTX
SVP, Chief Accounting Officer
1,671
0.0024%
$21.75$36,348-30.47%
2023-01-25SaleTravere Therapeutics, Inc.
TVTX
SVP, Chief Accounting Officer
192
0.0003%
$21.63$4,153-27.62%
2023-01-24SaleTravere Therapeutics, Inc.
TVTX
SVP, Chief Accounting Officer
905
0.0013%
$21.90$19,823-28.72%
2022-09-13SaleTravere Therapeutics, Inc.
TVTX
SVP, Chief Accounting Officer
349
0.0006%
$28.00$9,772-23.36%
Total: 23
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.